PRAME like-1 Inhibitors

Chemical inhibitors of PRAME-like-1 can disrupt the protein's functional activity through various cellular mechanisms. Benzyl isothiocyanate, by inhibiting melanoma cell proliferation, may intersect with pathways crucial for the activity of PRAME-like-1, leading to its functional inhibition. Disulfiram alters proteasome activity, which is pivotal for the degradation of proteins. Since PRAME-like-1 could be involved in ubiquitin-mediated pathways, disulfiram can inhibit its functional activity by impairing the proteasome's ability to process proteins that may be linked to PRAME-like-1's function. MG-132, a well-known proteasome inhibitor, prevents the breakdown of proteins involved in the degradation pathway of PRAME-like-1, thereby leading to an accumulation that could inhibit PRAME-like-1 function.

Bortezomib, similar to MG-132, inhibits the proteasome and could increase ubiquitination and subsequent degradation of PRAME-like-1, disrupting its normal function. Epigallocatechin gallate impacts cellular proliferation pathways and could inhibit PRAME-like-1's role in these pathways by modulating signal transduction. Indole-3-carbinol modulates cell growth and arrest, potentially inhibiting PRAME-like-1's function in growth regulation by altering the cell cycle. Resveratrol influences cell survival and death signaling pathways. By affecting these pathways, resveratrol can inhibit PRAME-like-1's role in cell survival. Sulforaphane interferes with cell cycle progression and can inhibit PRAME-like-1's function by promoting cell cycle arrest in phases where PRAME-like-1 is critical. Curcumin affects cell proliferation and survival pathways, which can inhibit PRAME-like-1 by altering the cellular environment. Piperlongumine selectively targets cancer cells by influencing oxidative stress responses and can inhibit PRAME-like-1's function in cell survival. Phenethyl isothiocyanate modifies signaling pathways and cell cycle regulators, potentially inhibiting the functional role of PRAME-like-1. Lastly, parthenolide targets the NF-κB pathway and, by doing so, can inhibit PRAME-like-1's function related to transcriptional regulation within this pathway.